aripiprazole has been researched along with fluvoxamine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ozdemir, B; Uzun, O | 1 |
| Azuma, J; Fujiwara, T; Hara, S; Hasunuma, T; Higashi, K; Katano, T; Kitahara, S; Koue, T; Kubo, M; Miyatake, M | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Jean-Baptiste, M; Mukai, Y; Two, A | 1 |
| Aubin, HJ; Daeppen, JB | 1 |
| Arikawa, A; Hayashida, K; Maebayashi, K; Matsunaga, H; Mito, H; Motoyama, M; Yamanishi, K | 1 |
| Amerio, A; Ghaemi, SN; Odone, A; Tonna, M | 1 |
| Del Yerro-Álvarez, MJ; Fernández-Sotos, P; Lozano-Vicario, L; Lozoya-Moreno, S | 1 |
2 review(s) available for aripiprazole and fluvoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Emerging pharmacotherapies for alcohol dependence: a systematic review focusing on reduction in consumption.
Topics: Alcohol Abstinence; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Aripiprazole; Flupenthixol; Fluvoxamine; Fructose; Humans; Naltrexone; Piperazines; Psychotropic Drugs; Quinolones; Topiramate | 2013 |
1 trial(s) available for aripiprazole and fluvoxamine
| Article | Year |
|---|---|
The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Fluvoxamine; Genetic Association Studies; Half-Life; Humans; Japan; Male; Metabolic Clearance Rate; Paroxetine; Piperazines; Polymorphism, Genetic; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Young Adult | 2012 |
8 other study(ies) available for aripiprazole and fluvoxamine
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Dysmorphic Disorders; Drug Partial Agonism; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Piperazines; Psychiatric Status Rating Scales; Quinolones; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2010 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; Combined Modality Therapy; Dopamine Agents; Female; Fluvoxamine; GABA Modulators; Humans; Lorazepam; Memantine; Neurosurgical Procedures; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2011 |
[A Case with Multiple Comorbidities of Obsessive-Compulsive and Related Disorders].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Dysmorphic Disorders; Clonazepam; Combined Modality Therapy; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Fluvoxamine; Haloperidol; Hoarding Disorder; Humans; Obsessive-Compulsive Disorder; Psychotherapy; Self-Injurious Behavior; Skin; Trichotillomania; Young Adult | 2015 |
The Osler's view: Treating comorbid bipolar disorder and obsessive-compulsive disorder.
Topics: Adult; Affect; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clomipramine; Depression, Postpartum; Diagnosis, Differential; Female; Fluvoxamine; Humans; Lithium Compounds; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 2017 |
Late onset obsessive-compulsive disorder (OCD): A case report.
Topics: Age of Onset; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Dementia; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Quetiapine Fumarate; Self-Injurious Behavior; Tomography, Emission-Computed, Single-Photon | 2020 |